Literature DB >> 34862217

Interstitial lung disease on the acute take for the non-respiratory physician.

Veronica Yioe1, Gerrard Phillips2, Lisa G Spencer3.   

Abstract

Interstitial lung diseases (ILDs) are a heterogeneous group of diseases characterised by varying degrees of fibrotic and/or inflammatory abnormalities of the lung parenchyma. Management of ILD is often challenging for non-respiratory physicians. We discuss the respiratory assessment and management of patients with ILD presenting with acute breathlessness on the acute take, including acute exacerbations of ILD. © Royal College of Physicians 2021. All rights reserved.

Entities:  

Keywords:  acute exacerbation of ILD; acute take; antifibrotic drugs; immunosuppression; interstitial lung disease

Mesh：

Year:  2021        PMID： 34862217      PMCID： PMC8806283          DOI： 10.7861/clinmed.2021-0694

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


  16 in total

1.  Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features.

Authors:  D S Kim; J H Park; B K Park; J S Lee; A G Nicholson; T Colby
Journal:  Eur Respir J       Date:  2006-01       Impact factor: 16.671

Review 2.  Risk of venous thromboembolism in patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis.

Authors:  Boonphiphop Boonpheng; Patompong Ungprasert
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

Review 3.  Acute exacerbations of progressive-fibrosing interstitial lung diseases.

Authors:  Martin Kolb; Benjamin Bondue; Alberto Pesci; Yasunari Miyazaki; Jin Woo Song; Nitin Y Bhatt; John T Huggins; Justin M Oldham; Maria L Padilla; Jesse Roman; Shane Shapera
Journal:  Eur Respir Rev       Date:  2018-12-21

4.  A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

Authors:  Talmadge E King; Williamson Z Bradford; Socorro Castro-Bernardini; Elizabeth A Fagan; Ian Glaspole; Marilyn K Glassberg; Eduard Gorina; Peter M Hopkins; David Kardatzke; Lisa Lancaster; David J Lederer; Steven D Nathan; Carlos A Pereira; Steven A Sahn; Robert Sussman; Jeffrey J Swigris; Paul W Noble
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

5.  Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.

Authors:  Luca Richeldi; Roland M du Bois; Ganesh Raghu; Arata Azuma; Kevin K Brown; Ulrich Costabel; Vincent Cottin; Kevin R Flaherty; David M Hansell; Yoshikazu Inoue; Dong Soon Kim; Martin Kolb; Andrew G Nicholson; Paul W Noble; Moisés Selman; Hiroyuki Taniguchi; Michèle Brun; Florence Le Maulf; Mannaïg Girard; Susanne Stowasser; Rozsa Schlenker-Herceg; Bernd Disse; Harold R Collard
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

6.  Prognostic significance of crazy paving ground grass opacities in non-HIV Pneumocystis jirovecii pneumonia: an observational cohort study.

Authors:  Shogo Kumagai; Machiko Arita; Takashi Koyama; Takao Kumazawa; Daiki Inoue; Atsushi Nakagawa; Yusuke Kaji; Kenjiro Furuta; Motonari Fukui; Keisuke Tomii; Yoshio Taguchi; Hiromi Tomioka; Tadashi Ishida
Journal:  BMC Pulm Med       Date:  2019-02-21       Impact factor: 3.317

7.  Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study.

Authors:  Hironao Hozumi; Yutaro Nakamura; Takeshi Johkoh; Hiromitsu Sumikawa; Thomas V Colby; Masato Kono; Dai Hashimoto; Noriyuki Enomoto; Tomoyuki Fujisawa; Naoki Inui; Takafumi Suda; Kingo Chida
Journal:  BMJ Open       Date:  2013-09-13       Impact factor: 2.692

Review 8.  Management of acute respiratory failure in interstitial lung diseases: overview and clinical insights.

Authors:  Paola Faverio; Federica De Giacomi; Luca Sardella; Giuseppe Fiorentino; Mauro Carone; Francesco Salerno; Jousel Ora; Paola Rogliani; Giulia Pellegrino; Giuseppe Francesco Sferrazza Papa; Francesco Bini; Bruno Dino Bodini; Grazia Messinesi; Alberto Pesci; Antonio Esquinas
Journal:  BMC Pulm Med       Date:  2018-05-15       Impact factor: 3.317

Review 9.  Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets.

Authors:  Beatriz Ballester; Javier Milara; Julio Cortijo
Journal:  Int J Mol Sci       Date:  2019-01-30       Impact factor: 5.923

10.  Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases.

Authors:  Takafumi Suda; Yusuke Kaida; Yutaro Nakamura; Noriyuki Enomoto; Tomoyuki Fujisawa; Shiro Imokawa; Hideo Hashizume; Tateaki Naito; Dai Hashimoto; Yasuo Takehara; Naoki Inui; Hirotoshi Nakamura; Thomas V Colby; Kingo Chida
Journal:  Respir Med       Date:  2009-02-01       Impact factor: 3.415
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.